These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7399939)

  • 21. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [What's new in upper gastrointestinal tract surgery?].
    Hölscher AH; Mönig SP; Schneider PM
    Zentralbl Chir; 2003 Jan; 128(1):2-5. PubMed ID: 12594605
    [No Abstract]   [Full Text] [Related]  

  • 24. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.
    Morganstern B; Anandasabapathy S
    Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
    Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
    Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
    Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
    Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic resection for Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Watson TJ
    Semin Thorac Cardiovasc Surg; 2008; 20(4):310-9. PubMed ID: 19251170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical manifestations and complications of gastroesophageal reflux disease (GERD).
    Malfertheiner P; Hallerbäck B
    Int J Clin Pract; 2005 Mar; 59(3):346-55. PubMed ID: 15857335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's esophagus.
    Attwood SE
    Curr Opin Gen Surg; 1993; ():180-8. PubMed ID: 7583962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
    Eng C; Spechler SJ; Ruben R; Li FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study.
    Rantanen TK; Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Am J Gastroenterol; 2006 Feb; 101(2):222-8. PubMed ID: 16454822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adenocarcinoma of the gastro-esophagus junction associated to endobrachyesophagus. Two case reports. Review of the literature].
    Kreiker J; Daou R
    J Med Liban; 2004; 52(2):103-10. PubMed ID: 15884690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Barrett esophagus and Barrett carcinoma].
    Kruyt PH; van Sandick JW; van Lanschot JJ; Offerhaus GJ; Tytgat GN; Obertop H
    Ned Tijdschr Geneeskd; 1997 May; 141(18):869-73. PubMed ID: 9273450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.